Project Grant W81XWH2110463
Award Date
7/1/21
Completion Date
6/30/22
Dollars Obligated
$923K
Federal Agency
Medical Command
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Basking Ridge, Bernards, NJ 07920, USA
Similar Awards
The U.S. Department of the Army Medical Command awarded a $5,099,737 Project Grant (CFDA 12.420 - Military Medical Research and Development) to 149 Bio LLC located in Miami, FL. The grant supports the development of a novel myeloid-targeted therapeutic for glomerular diseases, with a performance period from July 1, 2025 to June 30, 2029. This award is part of the Military Medical Research and Development program, which focuses on transforming healthcare for military service members and the...
The Defense Health Agency awarded Syracuse University a $1,099,513 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to develop antimicrobial shape memory polymer foams for rapid hemorrhage control and infection prevention in traumatic wounds. The grant period runs from August 15, 2023 to August 14, 2026. The research aims to transform health care for Service Members and the American public through innovative and impactful biomedical research focused on...
This Project Grant award from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), provides $4,000,000.00 in funding to Medcura, Inc. in Riverdale, MD to expand the development and production of a biopolymer powder treatment for noncompressible torso hemorrhage. The research aims to improve health outcomes for military service members and the broader public by advancing this innovative medical technology. The award period extends from Aug 5,...
The Department of the Army Medical Command, under the Military Medical Research and Development (CFDA 12.420) federal grant program, awarded a $1,999,583 Project Grant to IRR Inc. in Santa Barbara, CA. The grant supports an early-stage proof-of-concept study of a fixed-dose combination therapy in a high-fidelity porcine model of severe polytrauma. The project aims to transform healthcare for military service members and the broader public through innovative biomedical research. The performance...
Hbvtech received a $279,854 project grant award from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The award will support Hbvtech's research from May 2021 through April 2023 to develop a novel hepatitis B virus drug aimed at effectively curing chronic hepatitis B. The Military Medical Research and Development program seeks to transform military and public health through innovative medical research solutions,...
The Department of the Army Medical Command awarded a $818,337 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to Vascular Perfusion Solutions Inc. in San Antonio, Texas. The grant, with a performance period from August 15, 2025 to August 14, 2027, will fund research on "Extended Limb Stasis in the Encore Tissue Preservation Device". The Military Medical Research and Development program supports advanced biomedical research initiatives focused...
This federal Project Grant award of $808,141.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), will fund research to target inflammatory pathways in breast cancer brain metastases for the treatment of edema and radiation necrosis using anti-VEGF ultrasmall particle therapy. The grant, awarded to the Weill Medical College of Cornell University, will support advanced biomedical research initiatives focused on transforming...
The federal Project Grant award of $1,214,375.00 from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), is funding a research project led by Yale University. The project is investigating the use of decoy-resistant IL-18 and immune checkpoint inhibitors in preclinical murine and ex vivo patient-derived models of renal cell carcinoma. The award began on September 15, 2024 and is set to conclude on September 14, 2028. The Military Medical Research...
The Department of the Army Medical Command awarded Yale University a $1,004,997 project grant under the Military Medical Research and Development program (CFDA 12.420). The grant will fund Yale University's pilot development of new forms of chimeric antigen receptor therapies for kidney cancer from August 15, 2021 to August 14, 2024. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public health care through...
The Department of the Army Medical Command awarded a $1,347,700 Project Grant to Sloan-Kettering Institute For Cancer Research under the Military Medical Research and Development program (CFDA 12.420). The grant will support development of an implantable nanosensor for early-stage ovarian cancer detection from June 2022 through June 2025. The Military Medical Research and Development program aims to transform military and public health through innovative medical research solutions. This award...